|
|
| TOKYO SHINJUKU HEMOPHILIA CENTER |
Tokyo Medical University Hospital
Department of Laboratory Medicine
and Molecular Genetics of Coagulation Disorders
Coagulation, Transfusion Medicine and Infectious Diseases
The Hemophilia Treatment Center (HTC) in Tokyo Medical University Hospital
is providing a comprehensive care for hemophilia and other coagulation
disorders, working with related departments.
We are operating outpatient clinic from Mon. to Fri. (8:30-16:00) and Sat.
except 2nd & 4th Sat.(8:30-11:00). We have an emergency care for 24hrs.
Director:
Dr. Katsuyuki Fukutake , Professor and Chairman
Physicians:
Dr. Kagehiro Amano
Dr. Takeshi Hagiwara
Dr. Takashi Muramatsu
Dr. Kyoichi Ogata
Dr. Manabu Otaki
Dr Takashi Suzuki
Dr. Ikuo Seita
Dr. Yasuyuki Yamamoto
Dr. Mihoko Yotsumoto
Nurse Coordinator:
Ms. Chie Sato RN
BioMedical Researchers
Dr. Hiroshi Inaba, Ph.D.
Dr. Keiko Shinozawa, Ph.D.*
*Dept. of Molecular Genetics of Coagulation Disorders
Address: MAP
Tokyo Shinjuku Hemophilia Centre
Department of Laboratory Medicine
Tokyo Medical University Hospital
6-7-1 Nishi-shinnjuku, Shinjuku-Ku, Tokyo, Japan
160-0023
Phone: +81-3-3342-6111
Fax: +81-3-3340-5448
Email: fukutake@tokyo-med.ac.jp
Web site:http://labo-med.tokyo-med.ac.jp/
Available Coagulation factors
Factor VIII:
Recombinant; Advate (Baxter), KogenateFS (Bayer),
Plasma; Cross-eightM(Japan Red Cross)
Factor IX
Recombinant; Benefix(Wyeth)
Plasma; Novact M (Chemo-Thera), Christmasin M (Mitsubishi)
Inhibitor;
FEIBA (Baxter), NovoSeven (Novo Nordisk)
VWF;
Plasma; Confact F ( Chemo-Thera )
Factor XIII;
Plasma; Fibrogamin(CSL)
|
|
|
|
